Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3681652012 | Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3681653019 | Acetaminophen 500 mg and dihydrocodeine tartrate 10 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3681654013 | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
57004801000001111 | Co-dydramol 10mg/500mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing dihydrocodeine tartrate and paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Dihydrocodeine tartrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dihydrocodeine tartrate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Dihydrocodeine tartrate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Dihydrocodeine tartrate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing dihydrocodeine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Dihydrocodeine tartrate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing only dihydrocodeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Dihydrocodeine tartrate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Dihydrocodeine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 5 (CD Inv) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Dihydrocodeine tartrate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Co-dydramol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Paracetamol+dihydrocodeine tartrate 500mg/10mg tablet | Is a | False | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Alpharma Limited) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Approved Prescription Services) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (The Boots Company) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Galake 10mg/500mg tablets (Galen Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (IVAX Pharmaceuticals UK Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Kent Pharma (UK) Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Ranbaxy (UK) Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Zentiva Pharma UK Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Unichem Plc) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Accord Healthcare Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (M & A Pharmachem Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Almus Pharmaceutical Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 30 tablet | Is pack of | False | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 500 tablet | Is pack of | False | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 100 tablet | Is pack of | False | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Arrow Generics Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Medihealth (Northern) Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Wockhardt UK Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 100 tablet | Has VMP | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 30 tablet | Has VMP | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets 500 tablet | Has VMP | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Phoenix Healthcare Distribution Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Waymade Healthcare Plc) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-dydramol 10mg/500mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Eroset 500mg/10mg tablets (GlucoRx Ltd) | Is a | True | Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets